IPRATROPIUM bromide, 0.25mg/ml, 2ml, sol. for nebulizer
STD
DORAIPRA5N-
Valid Article
Account code:
60000
HS Code:
300490
Last Updated on:
09/08/2024, 22:03:46
Former
Code(s):
DORAZNL0311
25.1 - Antiasthmatic medicines and medicines for chronic obstructive pulmonary disease
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
R03BB01
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
IPRATROPIUM solution for nebulizer
- In the WHO list of Essential Medicines 2023 (Inhalation aerosol only)
Therapeutic Action
Inhaled anticholinergic bronchodilator
After inhalation, it causes rapid bronchodilation within minutes (approx. 3 min.) and lasting for 4-6 hours.
Indications
Symptoms related to bronchospasm in chronic obstructive pulmonary disease (COPD) in combination with salbutamol solution for nebuliser.
Severe acute life-threatening asthma, in association with salbutamol solution for nebuliser.
Instructions for use
Ready-to-use solution for inhalation to be given with a nebuliser and a mask.
2 different presentations:
- 1 ml ampoule containing 0.25 mg (= 250 µg) ipratropium bromide for paediatric use (< 6 years)
- 2 ml ampoule containing 0.50 mg (= 500 µg) for adults and children over 6 years
Method of administration:
- Assemble the nebuliser according to the manufacturer's instructions.
- Empty the required ipratropium solution into the nebuliser reservoir.
- Add salbutamol solution for nebuliser.
- Complete with 0.9% sodium chloride to obtain a total volume of 5 ml in the nebuliser reservoir.
- Avoid eye contact with the aerosol generated by the nebuliser.
- With pneumatic nebulisers, the flow of air or oxygen to pulse the solution will be adjusted according to the patient's condition and the manufacturer's recommendations.
- Nebulisation should not normally exceed 10-20 minutes.
- After nebulisation, any unused solution remaining in the nebuliser reservoir should be discarded.
- Follow the manufacturer's instructions for use, cleaning and maintenance of the nebuliser.
Precautions for Use
Only by inhalation route. Never use nebuliser solution by parenteral route.
Do not swallow.
Storage
Below 25°C ‐ Protect from sunlight